Keyword Connections

gene therapy

Journals

24

1 Scientific reports

2 The Analyst

3 current pharmaceutical biotechnology

4 Advanced drug delivery reviews

5 acs nano

6 nanomedicine (london, england)

7 journal of clinical medicine

8 Environmental science & technology

9 nanoscale research letters

10 saudi medical journal

11 Neuro-Oncology

12 expert opinion on therapeutic targets

13 Journal of molecular biology

14 Journal of Virology

15 drug delivery

16 european journal of pharmaceutics and biopharmaceutics : official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik ev

17 Current topics in medicinal chemistry

18 molecular biotechnology

19 experimental neurology

20 laboratory investigation; a journal of technical methods and pathology

21 Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

22 medical sciences (basel, switzerland)

23 journal of molecular and cellular cardiology

24 Annals of hematology

Research Groups

0

No Research Group Connected

Bibliographies

86

1 Gene therapy for hemophilia: Progress to date and challenges moving forward.

2 AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.

3 The Positive Fate of Biochar Addition to Soil in the Degradation of PHBV-Silver Nanoparticle Composites.

4 A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

5 Safety and efficacy of VB-111, an anti-cancer gene-therapy, in patients with recurrent glioblastoma: results of a phase I/II study.

6 Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs.

7 Engineering anisotropic cardiac monolayers on microelectrode arrays for non-invasive analyses of electrophysiological properties.

8 Large-Scale Production of Adeno-Associated Viral Vector Serotype-9 Carrying the Human Survival Motor Neuron Gene.

9 Impact of nutritional stress on the honeybee colony health.

10 Knowledge and practices of dentists regarding MERS-CoV. A cross-sectional survey in Saudi Arabia.

11 Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.

12 Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies.

13 Pigs with δ-sarcoglycan deficiency exhibit traits of genetic cardiomyopathy.

14 Nucleofection of phiC31 Integrase Protein Mediates Sequence-Specific Genomic Integration in Human Cells.

15 foamy virus vectors for hiv gene therapy

16 cell and gene therapy approaches for cardiac vascularization

17 antitumor cell-complex vaccines employing genetically modified tumor cells and fibroblasts

18 minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type ia

19 adeno-associated viral vector delivered rnai for gene therapy of sod1 amyotrophic lateral sclerosis

20 progress in gene therapy

21 gene therapy for the treatment of parkinson’s disease: the nature of the biologics expands the future indications

22 folate-conjugated polyspermine for lung cancer–targeted gene therapy

23 mutational analysis of dbd*-a unique antileukemic gene sequence

24 the interplay of post-translational modification and gene therapy

25 non-clinical safety and efficacy of an aav2/8 vector administered intravenously for treatment of mucopolysaccharidosis type vi

26 editorial: gene therapy for the central and peripheral nervous system

27 non-primate lentiviral vectors and their applications in gene therapy for ocular disorders

28 highly branched poly(5-amino-1-pentanol-co-1,4-butanediol diacrylate) for high performance gene transfection

29 gene therapy in glaucoma-part 2: genetic etiology and gene mapping

30 full-length dysferlin transfer by the hyperactive sleeping beauty transposase restores dysferlin-deficient muscle

31 integrin activation: implications for axon regeneration

32 evaluating efficiencies of dual aav approaches for retinal targeting

33 emerging issues in aav-mediated in vivo gene therapy

34 optimization of a neural stem-cell-mediated carboxylesterase/irinotecan gene therapy for metastatic neuroblastoma

35 experimental gene therapy with serine-histogranin and endomorphin 1 for the treatment of chronic neuropathic pain

36 transient expression of an ledgf/p75 chimera retargets lentivector integration and functionally rescues in a model for x-cgd

37 terapia génica con citocinas contra cáncer cervicouterino gene therapy with cytokines against cervical cancer

38 autoimmune dysregulation and purine metabolism in adenosine deaminase (ada)-deficiency

39 hiv, leukemia, and new horizons in molecular therapy

40 platelet gene therapy promotes targeted peripheral tolerance by clonal deletion and induction of antigen-specific regulatory t cells

41 virus wars: using one virus to block the spread of another

42 dna ministrings: highly safe and effective gene delivery vectors

43 efficient restoration of the dystrophin gene reading frame and protein structure in dmd myoblasts using the cindel method

44 construcción de un vector de expresión derivado de virus adenoasociados para corregir in vitro el defecto genético de la enfermedad de morquio a

45 potential of caveolae in the therapy of cardiovascular and neurological diseases

46 genetically engineered multilineage-differentiating stress-enduring cells as cellular vehicles against malignant gliomas

47 improving left ventricular myocardial function after myocardial infarction

48 the challenge of vector development in gene therapy

49 aav-mediated gene supplementation therapy in achromatopsia type 2: preclinical data on therapeutic time window and long-term effects

50 Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

51 Gene-activated fat grafts for the repair of spinal cord injury: a pilot study

52 Gene targeting in ischemic heart disease and failure: Translational and clinical studies

53 Efficacy of Axicabtagene Ciloleucel Compared to Historical Treatments for Relapsed/Refractory Diffuse Large B-Cell Lymphoma of Asian Descent: A Matching Adjusted Indirect Comparison of ZUMA-1 vs REAL-TREND.

54 Determination of the activity of uracil-DNA glycosylase by using two-tailed reverse transcription PCR and gold nanoparticle-mediated silver nanocluster fluorescence: a new method for gene therapy-related enzyme detection

55 Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada.

56 Enhanced regeneration and reinnervation following timed GDNF gene therapy in a cervical ventral root avulsion.

57 ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology

58 Immuno-Oncology - The Translational Runway for Gene Therapy: Gene Therapeutics to Address Multiple Immune Targets

59 Polysaccharide-coated magnetic nanoparticles for imaging and gene therapy

60 Erratum: Correction to Simultaneous Diagnosis and Gene Therapy of Immuno-Rejection in Rat Allogeneic Heart Transplantation Model Using a T-Cell-Targeted Theranostic Nanosystem (ACS nano (2012) 6 12 (10646-10657))

61 Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.

62 Comparisons of Infant and Adult Mice Reveal Age Effects for Liver Depot Gene Therapy in Pompe Disease.

63 Emerging patent landscape for non-viral vectors used for gene therapy.

64 Chemogenetics a robust approach to pharmacology and gene therapy

65 Will airway gene therapy for cystic fibrosis improve lung function? New imaging technologies can help us find out.

66 cationic polyene phospholipids as dna carriers for ocular gene therapy

67 towards routine manufacturing of gene therapy drugs

68 cutting-edge trends on regenerative therapy: induced embryonic and pluripotential stem cells, angiogenic growth factor and gene therapy

69 intricacies for posttranslational tumor-targeted cytokine gene therapy

70 ocular and systemic safety of a recombinant aav8 vector for x-linked retinoschisis gene therapy: glp studies in rabbits and rs1-ko mice

71 gene therapy in medicine

72 clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives

73 zarogouldis, p., et al., vectors for inhaled gene therapy in lung cancer. application for nano oncology and safety of bio nanotechnology. int. j. mol. sci. 2012, 13, 10828-10862

74 current challenges and future directions in recombinant aav-mediated gene therapy of duchenne muscular dystrophy

75 manufacturing of acmnpv baculovirus vectors to enable gene therapy trials

76 bacteriophage-derived vectors for targeted cancer gene therapy

77 connexin 43 gene therapy delivered by polymer-modified salmonella in murine tumor models

78 the relationship between the antitumor effect of the il-12 gene therapy and the expression of th1 cytokines in an hpv16-positive murine tumor model

79 a double-switch cell fusion-inducible transgene expression system for neural stem cell-based antiglioma gene therapy

80 accelerated wound healing: harnessing the power of platelets, biomaterials, stem cells and gene therapy

81 gene therapy and its approaches in the treatment of oral cancer – a review

82 commentary: gene therapy: a promising approach for neuroprotection in parkinson's disease?

83 episomal nonviral gene therapy vectors slow progression of atherosclerosis in a model of familial hypercholesterolemia

84 novel viral vector systems for gene therapy

85 experimental study of local inner ear gene therapy for controlling autoimmune sensorineural hearing loss

86 A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion